Drug resistance in hematologic malignancies: induction mechanisms, genetics, and therapeutics

Biomed Res Int. 2015:2015:384575. doi: 10.1155/2015/384575. Epub 2015 Apr 27.

Authors

Fenghuang Zhan¹, Maurizio Zangari², Lugui Qiu³

Affiliations

¹ Department of Internal Medicine, The University of Iowa, Roy J. and Lucille A. Carver College of Medicine, Iowa City, IA 52242, USA.
² Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
³ State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin 300020, China.

No abstract available

Publication types

Editorial
Introductory Journal Article

MeSH terms

Antineoplastic Agents / therapeutic use*
Drug Resistance, Neoplasm
Hematologic Neoplasms / drug therapy*
Hematologic Neoplasms / genetics*
Humans
Neoplastic Stem Cells / pathology

Substances

Antineoplastic Agents